Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality.
Wegovy® (semaglutide) is Novo Nordisk’s FDA-approved brand-name, once-weekly injectable medication specifically designed to support chronic weight management in adults who are overweight or obese. Developed by Novo Nordisk, Wegovy has revolutionized weight loss treatment by targeting the body’s appetite regulation and insulin response mechanisms. It is intended for adults with:
- A BMI of 30 or greater (obesity)
- Or a BMI of 27 or greater (overweight) with at least one weight-related medical condition such as high blood pressure, type 2 diabetes, or high cholesterol
Wegovy® for Weight Loss – What You Need to Know
How Wegovy® Works
Wegovy® contains semaglutide , a GLP-1 receptor agonist , which mimics a naturally occurring hormone in the body that:
- Increases insulin secretion
- Reduces appetite
- Slows gastric emptying (how quickly food leaves the stomach)
- Helps regulate blood sugar levels
By working through these pathways, Wegovy helps you feel full longer, eat less, and lose weight effectively when combined with a reduced-calorie diet and increased physical activity.
Efficacy and Results
In STEP 1 (New England Journal of Medicine, 2021), Wegovy averaged a 14.9% loss of starting body weight over 68 weeks alongside diet and exercise, against 2.4% for placebo.
Key findings from the STEP clinical trial program include:
- 83.5% of patients lost ≥5% of body weight
- 66% lost ≥10% of body weight
- 50.5% lost ≥15% of body weight
Individual results will vary. This is not a guarantee of outcome.
Explore our products
Wegovy®
This is for exam and prescription only and we will assist you with getting your medications directly from the Novo Nordisk Direct Pharmacy
Compounded Semaglutide
Compounded semaglutide is a breakthrough weight loss medication that contains the same drug substance used in GLP-1 receptor agonist therapy.
Common questions
Do you carry brand-name Wegovy, or only a compounded version?
Both. We carry brand-name Wegovy and also offer personalized compounded semaglutide through a licensed U.S. 503a pharmacy. Your provider goes over both options and what fits your history before you decide which one you start on.
How do I know which one is right for me?
Your provider decides after reviewing your labs, medical history and what you have already tried. Some patients start on brand-name Wegovy, others on the compounded version — the choice is clinical, not based on price alone.
Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. Made Ya Skinny is not affiliated with, endorsed by or sponsored by either company, and does not sell their products. Brand names appear here to identify the medicine being discussed.
Choose office or telehealth care, complete the weight-loss prescreen, and reserve your visit online. Approval does not mean somebody will call; continue online, with text or email updates along the way.